The René Leriche memorial lecture. The thrombo-embolic threat.
D000925:Anticoagulants / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D011183:Postoperative Complications; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D013300:Streptokinase / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013924:Thrombophlebitis / Q000188:drug therapy / Q000601:surgery; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D000925:Anticoagulants; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator